MedPath

Tissue-specific Effects of Insufficient Sleep

Not Applicable
Active, not recruiting
Conditions
Healthy
Interventions
Behavioral: Insufficient sleep
Registration Number
NCT03437681
Lead Sponsor
University of Colorado, Denver
Brief Summary

This study plans to learn more about how sleep loss impacts the way the body responds to sugar. This work will have important implications for development of treatments and countermeasures for people who are not able to get enough sleep for various reasons.

Detailed Description

Participants will stay in the hospital for 6 days and will not be able to leave. Sleep habits will be measured for 7 days before the study. A research diet that is designed to maintain weight will be provided for 3 days before the study and during the study. Multiple tests will be performed, including metabolic testing and muscle and fat biopsies, both when participants first arrive and have had normal sleep and again after 4 nights of only 5 hours time in bed. The visit takes place at the Clinical Translational Research Center (CTRC) at the University of Colorado Denver, Anschutz Medical campus. It will take approximately 2 weeks to complete this study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Current or history of any clinically significant medical, psychiatric, or sleep disorder.
  2. Use or history of any drugs, medications, supplements, caffeine, and alcohol.
  3. Current or history of shiftwork in six months prior to laboratory study.
  4. Travel more than one time zone in three weeks prior to laboratory study.
  5. Blood donation in the 30 days prior to inpatient study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Insufficient sleepInsufficient sleepEach participant will receive 4 nights of insufficient sleep.
Primary Outcome Measures
NameTimeMethod
Change in insulin sensitivityOne week

Insulin sensitivity measured by hyperinsulinemic euglycemic clamp.

Secondary Outcome Measures
NameTimeMethod
Changes in microvascular functionOne week

Macrovascular function will be assessed with EndoPAT

Changes in cognitive abilitiesOne week

Cognitive computer tests performed during study

Changes in metabolic tissue functionOne week

Tissue biopsies will be performed

Changes in macrovascular functionOne week

Macrovascular function will be assessed with flow-mediated dilation

Changes in circadian rhythmsOne week

Salivary dim-light melatonin offset will be assessed

Trial Locations

Locations (1)

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath